QUARK PHARMACEUTICALS INC of FREMONT, CA, a company, filed a Form D exempt-offering notice with the SEC on 2010-06-01. The offering totals $10.0M, of which $10.0M was reported sold. Industry: Pharmaceuticals.
| Name | Role | Location |
|---|---|---|
| Trent M Gunter | Director | Fremont, CA |
| Philip M Hahn | Director | Fremont, CA |
| Kazuyuki B Matsui | Director | Fremont, CA |
| Toru B Mio | Director | Fremont, CA |
| Philip B Simon | Director | Fremont, CA |
| Peter A Thompson, M.D. | Director | Fremont, CA |
| Daniel Zurr, Ph.D. | Director | Fremont, CA |
| Carlos D Benaim, M.Sc. | Executive Officer | Fremont, CA |
| Shai Erlich, Ph.D. | Executive Officer | Fremont, CA |
| Elena Feinstein, Ph.D. | Executive Officer | Fremont, CA |
| Juliana Friedmann, M.Sc. | Executive Officer | Fremont, CA |
| Robert L Jones | Executive Officer | Arlington, TX |
| Smadar Shakked | Executive Officer | Fremont, CA |
| Rami Skaliter | Executive Officer | Fremont, CA |
| James D Thompson, Ph.D. | Executive Officer | Fremont, CA |
| Daniel Zurr, Ph.D. | Executive Officer | Fremont, CA |